Home › Merck KGaA brain tumor drug fails clinical trial
 

Keywords :   


Merck KGaA brain tumor drug fails clinical trial

2013-02-25 15:33:17| Biotech - Topix.net

Merck KGaA's Cilengitide, an experimental drug to treat an aggressive type of brain tumor, has failed a large-scale clinical trial, dealing a blow to the German drugmaker's efforts to replenish its pipeline of medicines.

Tags: trial drug clinical brain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Forecast Discussion Number 9
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 19
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 9
28.09Hurricane Isaac Forecast Advisory Number 9
More »